Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. (603392)

Overview

Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. is a prominent player in the global health sector, focusing on the research, development, production, distribution, and sale of diagnostic reagents and vaccines for infectious diseases. Established in 1991 and based in Beijing, China, the company has extended its reach both domestically and internationally. Dedicated to addressing critical health challenges, Beijing Wantai provides a wide array of diagnostic solutions for diseases such as COVID-19, HIV, Hepatitis, and Tuberculosis. Additionally, the company is at the forefront in developing vaccines for Hepatitis E and human papillomavirus (HPV), contributing to global efforts in disease prevention and control. Serving a diverse clientele, including blood banks, hospitals, clinics, reference laboratories, border inspection centers, blood-processing companies, and research institutes, Beijing Wantai stands as a vital supporter of public health and safety worldwide.

Products and Services

• COVID-19 Diagnostics Test Kits:

  Advanced diagnostic tools designed for the detection and confirmation of COVID-19 cases, facilitating timely and accurate diagnosis essential for controlling the pandemic.

• HIV and HTLV Diagnostics Test Kits:

  Comprehensive testing solutions for the detection of Human Immunodeficiency Virus (HIV) and Human T-lymphotropic Virus (HTLV), crucial for blood safety and managing viral infections.

• Hepatitis Diagnostics Test Kits:

  Specific reagents for the diagnosis of various hepatitis viruses, supporting efforts in monitoring and treating viral liver diseases.

• EV-71 Diagnostics Test Kits:

  Dedicated kits for the detection of Enterovirus 71, responsible for causing hand, foot, and mouth disease (HFMD), enhancing outbreak response and child health care.

• Tuberculosis (TB) Diagnostics Test Kits:

  Innovative tests for the rapid and reliable diagnosis of Tuberculosis, a critical tool in the global fight against TB.

• Hepatitis C and Syphilis Detection Reagents:

  High-quality reagents for the detection of Hepatitis C Virus (HCV) and Syphilis, aiding in the effective diagnosis and management of these infectious diseases.

• Automated Immunoassays:

  State-of-the-art automated systems for the efficient and accurate conducting of immunoassays in various clinical settings.

• ELISA Kits and Rapid Tests for Infectious Disease Diagnostics:

  Extensive range of ELISA kits and rapid testing tools for the swift diagnosis of infectious diseases, supporting rapid decision-making.

• Chemiluminescence and Clinical Chemistry Reagents:

  Advanced reagents for chemiluminescence immunoassays and clinical chemistry, providing essential diagnostics information for healthcare professionals.

• Immunodiagnostic Reagents:

  Specialized reagents designed for the detection of immune responses to various diseases, facilitating the diagnosis and monitoring of immune status.

• Hepatitis E and Human Papillomavirus (HPV) Vaccines:

  Innovative vaccines aimed at preventing Hepatitis E and HPV infections, contributing significantly to public health by reducing the incidence of these diseases.